GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 174 filers reported holding GENMAB A/S in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,065,136 | -7.5% | 26,877 | -10.5% | 0.21% | -13.2% |
Q3 2022 | $1,151,000 | +11.7% | 30,016 | -0.2% | 0.24% | +13.6% |
Q2 2022 | $1,030,000 | +2.8% | 30,065 | +7.4% | 0.21% | +15.1% |
Q1 2022 | $1,002,000 | +11.7% | 27,994 | +1.7% | 0.19% | +11.4% |
Q4 2021 | $897,000 | -38.6% | 27,529 | -12.5% | 0.17% | -26.4% |
Q3 2021 | $1,461,000 | +4.4% | 31,453 | +2.5% | 0.23% | -0.4% |
Q2 2021 | $1,399,000 | +23.2% | 30,683 | +0.6% | 0.23% | +11.8% |
Q1 2021 | $1,136,000 | -4.3% | 30,505 | +4.3% | 0.20% | -6.8% |
Q4 2020 | $1,187,000 | +4.8% | 29,248 | +1.8% | 0.22% | -5.2% |
Q3 2020 | $1,133,000 | +13.0% | 28,737 | -2.9% | 0.23% | -21.4% |
Q2 2020 | $1,003,000 | – | 29,597 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |